Provera

One drug can have many contradictory uses - Lindsay Schlegel

Provera

HWN Suggests

Common questions about medroxyprogesterone tablets

Medroxyprogesterone works in the same way as the hormone progesterone that's made naturally in the body, but has a stronger effect. If you take it for conditions such as period problems, it makes the lining of the womb thinner and controls the timing of your monthly cycle. This can delay bleeding until after you stop taking the tablets. It can make periods lighter and shorter. It may also help with premenstrual symptoms. When taken as part of hormone replacement therapy (HRT), it works by replacing the hormone levels that fall during and after the menopause, which helps to improve menopause symptoms.

read full article

Featured

 How Progestin, a Synthetic Female Hormone, Could Affect the Brain

Used widely in contraceptions and in hormone replacement therapy during menopause, progestins affect a lot more than just the uterus.

Articles of Interest

Abnormal Uterine Bleeding: A Review

Medroxyprogesterone acetate, at a higher dosage of 20 mg three times daily for 7 days, may be used for acute AUB symptoms. For chronic AUB, norethindrone, megestrol acetate, micronized progesterone, or lower doses of medroxyprogesterone acetate (2.5-10 mg) may be used for chronic AUB

Can I take medroxyprogesterone (MP) 20 mg short term to stop vaginal bleeding?

Medroxyprogesterone acetate 20 mg can be effectively used short-term to stop acute vaginal bleeding, typically administered every 8 hours for 3 days.

Medroxyprogesterone Acetate for Abnormal Uterine Bleeding Due to Ovulatory Dysfunction: The Effect of 2 Different-Duration Regimens

According to the results of our study, prolonged use of MPA in women with bleeding for more than 10 days in the treatment of AUB-O is not sufficient to regulate the cycles. However, in women who bleed for less than 10 days, 10-day use is effective and has an advantage in terms of dose and time-related adverse effects.

Medroxyprogesterone Dosage

5 or 10 mg daily for 5 to 10 days, beginning on the 16 th or 21 st day of the menstrual cycle

pms-Medroxyprogesterone

Medroxyprogesterone has a variety of uses. It is used in addition to postmenopausal estrogen replacement therapy (ERT) to prevent estrogen from thickening the lining of the uterus (endometrial hyperplasia). This significantly reduces the risk of endometrial cancer. It is also used to treat irregular menstrual cycles, lack of menstruation, and abnormal menstrual bleeding. Medroxyprogesterone is also used alone or in combination with other cancer medications to treat endometrial cancer and breast cancer. This medication may be available under multiple brand names and/or in several different forms. Any specific brand name of this medication may not be available in all of the forms or approved for all of the conditions discussed here. As well, some forms of this medication may not be used for all of the conditions discussed here.

Provera Side Effects Both Common and Severe

Provera (medroxyprogesterone acetate) may cause side effects, including headaches, facial hair growth, upset stomach, and changes in your menstrual cycle. Serious side effects could include vision changes, shortness of breath, and jaundice. Provera is prescribed to treat some causes of female hormone imbalance that lead to menstrual cycle disruptions or heavy bleeding. It will bring on a period between three and seven days after you finish taking a five- to 10-day course of treatment.

What is the use of Provera (medroxyprogesterone) in Abnormal Uterine Bleeding (AUB)?

Provera (medroxyprogesterone acetate) is an effective treatment for abnormal uterine bleeding (AUB), with a recommended regimen of 10 mg orally daily for 10-14 days, as supported by the most recent guidelines 1 . For acute management of heavy bleeding, a higher dose of 20 mg three times daily for 7 days can be used. After the initial treatment, cyclic therapy can be continued with 10 mg daily for 10-14 days each month to regulate cycles. To implement this treatment:

Resources

Healio

This medication has several uses. In women who are not pregnant and not going through menopause, this medication is used to treat abnormal bleeding from the uterus and to restore normal menstrual periods in women who have stopped having them for several months (amenorrhea).

Medroxyprogesterone (oral route)

Medroxyprogesterone is used to treat amenorrhea (unusual stopping of menstrual periods) and abnormal uterine bleeding. It is also used to prevent endometrial hyperplasia (thickening of the lining of the uterus or womb) in women who are taking conjugated estrogens. This medicine is a progestin hormone.

Provera

Medroxyprogesterone belongs to the family of medications known as progestins. Progestins are female hormones. They are produced by the body and are necessary along with other hormones for normal female sexual development and for the regulation of the menstrual cycle during childbearing years. Medroxyprogesterone reduces the effects of estrogen on tissues such as the endometrium (lining of the uterus) and the breast. Medroxyprogesterone has a variety of uses. It is used in addition to postmenopausal estrogen replacement therapy (ERT) to prevent estrogen from thickening the lining of the uterus (endometrial hyperplasia). This significantly reduces the risk of endometrial cancer. It is also used to treat irregular menstrual cycles, lack of menstruation, and abnormal menstrual bleeding. Medroxyprogesterone is also used alone or in combination with other cancer medications to treat endometrial cancer and breast cancer.

StatPearls

Medroxyprogesterone is used to prevent pregnancy in females of reproductive potential and for women experiencing amenorrhea due to hormonal imbalance, excluding organic pathologies such as fibroids and uterine cancer. Additionally, medroxyprogesterone is used for abnormal uterine bleeding due to ovulatory dysfunction, prevention of endometrial hyperplasia, pain related to endometriosis, and in patients with inoperable, recurrent, and/or metastatic endometrial carcinoma as adjunctive and/or palliative treatment.

stay connected